Skip to main content
Fig. 3 | BMC Ophthalmology

Fig. 3

From: Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization

Fig. 3

Left eye of a patient with morphological improvement after the first follow-up period and ICNV recurrence. At baseline, BCVA was 65 letters and the colour fundus photo (a) showed a pigmentation disorder of the macular centre. SD-OCT (b) showed CNV lesions with intraretinal fluid, and the structure of each layer of the retina was unclear. Five months later, after the second intravitreal injection, BCVA improved to 75 letters and OCT (c) showed that CNV lesions had subsided with recovery of foveal contour. Eighteen months after initial diagnosis, OCT (d) showed recurred intraretinal fluid, and the thickness of fovea increased significantly. One month after an additional intravitreal anti-VEGF therapy (e), the fovea returned to normal with the CNV lesions having completely subsided

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us